Suppr超能文献

乙型肝炎病毒感染的发病机制。

Pathogenesis of hepatitis B virus infection.

作者信息

Chisari F V, Isogawa M, Wieland S F

机构信息

Department of Immunology and Microbial Science, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

出版信息

Pathol Biol (Paris). 2010 Aug;58(4):258-66. doi: 10.1016/j.patbio.2009.11.001. Epub 2010 Feb 8.

Abstract

The adaptive immune response is thought to be responsible for viral clearance and disease pathogenesis during hepatitis B virus infection. It is generally acknowledged that the humoral antibody response contributes to the clearance of circulating virus particles and the prevention of viral spread within the host while the cellular immune response eliminates infected cells. The T cell response to the hepatitis B virus (HBV) is vigorous, polyclonal and multispecific in acutely infected patients who successfully clear the virus and relatively weak and narrowly focussed in chronically infected patients, suggesting that clearance of HBV is T cell dependent. The pathogenetic and antiviral potential of the cytotoxic T lymphocyte (CTL) response to HBV has been proven by the induction of a severe necroinflammatory liver disease following the adoptive transfer of HBsAg specific CTL into HBV transgenic mice. Remarkably, the CTLs also purge HBV replicative intermediates from the liver by secreting type 1 inflammatory cytokines thereby limiting virus spread to uninfected cells and reducing the degree of immunopathology required to terminate the infection. Persistent HBV infection is characterized by a weak adaptive immune response, thought to be due to inefficient CD4+ T cell priming early in the infection and subsequent development of a quantitatively and qualitatively ineffective CD8+ T cell response. Other factors that could contribute to viral persistence are immunological tolerance, mutational epitope inactivation, T cell receptor antagonism, incomplete down-regulation of viral replication and infection of immunologically privileged tissues. However, these pathways become apparent only in the setting of an ineffective immune response, which is, therefore, the fundamental underlying cause. Persistent infection is characterized by chronic liver cell injury, regeneration, inflammation, widespread DNA damage and insertional deregulation of cellular growth control genes, which, collectively, lead to cirrhosis of the liver and hepatocellular carcinoma.

摘要

适应性免疫反应被认为在乙型肝炎病毒感染期间负责病毒清除和疾病发病机制。一般认为,体液抗体反应有助于清除循环中的病毒颗粒并防止病毒在宿主体内传播,而细胞免疫反应则消除被感染的细胞。在成功清除病毒的急性感染患者中,T细胞对乙型肝炎病毒(HBV)的反应强烈、多克隆且具有多特异性,而在慢性感染患者中则相对较弱且聚焦范围狭窄,这表明HBV的清除依赖于T细胞。将HBsAg特异性细胞毒性T淋巴细胞(CTL)过继转移到HBV转基因小鼠后,引发了严重的坏死性炎症性肝病,这证明了CTL对HBV的致病和抗病毒潜力。值得注意的是,CTL还通过分泌1型炎性细胞因子从肝脏中清除HBV复制中间体,从而限制病毒传播到未感染的细胞,并降低终止感染所需的免疫病理学程度。持续性HBV感染的特征是适应性免疫反应较弱,这被认为是由于感染早期CD4 + T细胞启动效率低下,以及随后出现数量和质量上均无效的CD8 + T细胞反应。其他可能导致病毒持续存在的因素包括免疫耐受、突变表位失活、T细胞受体拮抗、病毒复制的不完全下调以及免疫特权组织的感染。然而,这些途径仅在免疫反应无效的情况下才会显现出来,因此,免疫反应无效是根本的潜在原因。持续性感染的特征是慢性肝细胞损伤、再生、炎症、广泛的DNA损伤以及细胞生长控制基因的插入失调,这些共同导致肝硬化和肝细胞癌。

相似文献

1
Pathogenesis of hepatitis B virus infection.
Pathol Biol (Paris). 2010 Aug;58(4):258-66. doi: 10.1016/j.patbio.2009.11.001. Epub 2010 Feb 8.
2
Hepatitis B virus immunopathogenesis.
Annu Rev Immunol. 1995;13:29-60. doi: 10.1146/annurev.iy.13.040195.000333.
3
Hepatitis B virus immunopathology.
Springer Semin Immunopathol. 1995;17(2-3):261-81. doi: 10.1007/BF00196169.
4
Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.
Curr Top Microbiol Immunol. 1996;206:149-73. doi: 10.1007/978-3-642-85208-4_9.
5
[Immunopathology of chronic liver diseases].
Verh Dtsch Ges Pathol. 1995;79:186-97.
6
Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):499-512. doi: 10.1586/egh.09.50.
7
Immunobiology of hepatitis B virus infection.
Hepatol Res. 2015 Jan;45(2):179-89. doi: 10.1111/hepr.12439. Epub 2014 Nov 26.
8
Breaking Hepatitis B Virus Tolerance and Inducing Protective Immunity Based on Mimicking T Cell-Independent Antigen.
Viral Immunol. 2016 Nov;29(9):502-509. doi: 10.1089/vim.2016.0052. Epub 2016 Sep 23.

引用本文的文献

1
MSP-RON signaling in liver pathobiology and as an emerging therapeutic target: a review of the current evidence.
Cell Commun Signal. 2025 Aug 28;23(1):385. doi: 10.1186/s12964-025-02407-5.
2
Illuminating HBV with multi-scale modeling.
Front Syst Biol. 2023 Feb 20;3:1045754. doi: 10.3389/fsysb.2023.1045754. eCollection 2023.
3
Association of TLR3 1337C/T and 1234C/T polymorphisms with chronic hepatitis B virus infection in Sudanese patients: A case-control study.
J Int Med Res. 2025 Jul;53(7):3000605251358062. doi: 10.1177/03000605251358062. Epub 2025 Jul 24.
4
AAV-HBV mouse model replicates the intrahepatic immune landscape of chronic HBV patients at single-cell level.
Front Immunol. 2025 Jun 18;16:1421712. doi: 10.3389/fimmu.2025.1421712. eCollection 2025.
5
Discovery of novel HBV core protein inhibitors by high throughput virtual screening.
Sci Rep. 2025 Apr 16;15(1):13054. doi: 10.1038/s41598-025-97242-6.
6
Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection.
CPT Pharmacometrics Syst Pharmacol. 2025 Mar;14(3):420-434. doi: 10.1002/psp4.13298. Epub 2024 Dec 27.
8
Association of HLA-G 3'UTR polymorphisms with hepatitis B virus infection in Tunisian population.
Immunol Res. 2024 Oct;72(5):1136-1146. doi: 10.1007/s12026-024-09516-2. Epub 2024 Jul 6.

本文引用的文献

1
The size of the viral inoculum contributes to the outcome of hepatitis B virus infection.
J Virol. 2009 Oct;83(19):9652-62. doi: 10.1128/JVI.00867-09. Epub 2009 Jul 22.
2
Immunobiology and pathogenesis of viral hepatitis.
Annu Rev Pathol. 2006;1:23-61. doi: 10.1146/annurev.pathol.1.110304.100230.
4
Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA.
Clin Cancer Res. 2005 Aug 15;11(16):5821-6. doi: 10.1158/1078-0432.CCR-04-2055.
6
Oscillating CD8(+) T cell effector functions after antigen recognition in the liver.
Immunity. 2005 Jul;23(1):53-63. doi: 10.1016/j.immuni.2005.05.005.
7
Stealth and cunning: hepatitis B and hepatitis C viruses.
J Virol. 2005 Aug;79(15):9369-80. doi: 10.1128/JVI.79.15.9369-9380.2005.
9
Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids.
Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9913-7. doi: 10.1073/pnas.0504273102. Epub 2005 Jul 1.
10
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
J Virol. 2005 Jun;79(11):7269-72. doi: 10.1128/JVI.79.11.7269-7272.2005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验